Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.87M
2: EX-19.1 Report Furnished to Security Holders HTML 63K
3: EX-21.1 Subsidiaries List HTML 26K
4: EX-23.1 Consent of Expert or Counsel HTML 25K
9: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 27K Awarded Compensation
5: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
15: R1 Cover Page HTML 95K
16: R2 Audit Information HTML 31K
17: R3 Consolidated Balance Sheets HTML 174K
18: R4 Consolidated Balance Sheets (Parenthetical) HTML 52K
19: R5 Consolidated Statements of Operations HTML 125K
20: R6 Consolidated Statements of Cash Flows HTML 180K
21: R7 Consolidated Statement Of Changes In Stockholders' HTML 228K
Equity (Deficit)
22: R8 Consolidated Statement Of Changes In Stockholders' HTML 27K
Equity (Deficit) - Parenthetical (Details)
23: R9 Nature of Operations HTML 34K
24: R10 Summary of Significant Accounting Policies HTML 81K
25: R11 Acquisitions HTML 83K
26: R12 Fixed Assets HTML 37K
27: R13 Intangible Assets and Goodwill HTML 82K
28: R14 Convertible Promissory Notes - Related Party HTML 38K
29: R15 Notes Payable HTML 48K
30: R16 Note Payable - Related Party HTML 30K
31: R17 Amount Due To Seller HTML 29K
32: R18 Stockholders' Equity (Deficit) HTML 79K
33: R19 Fair Value HTML 78K
34: R20 Related-Party Transactions HTML 32K
35: R21 Defined Contribution Plan HTML 28K
36: R22 Commitments HTML 37K
37: R23 Income Taxes HTML 83K
38: R24 Subsequent Events HTML 36K
39: R25 Pay vs Performance Disclosure HTML 38K
40: R26 Insider Trading Arrangements HTML 32K
41: R27 Summary of Significant Accounting Policies HTML 123K
(Policies)
42: R28 Summary of Significant Accounting Policies HTML 38K
(Tables)
43: R29 Acquisitions (Tables) HTML 75K
44: R30 Fixed Assets (Tables) HTML 36K
45: R31 Intangible Assets and Goodwill (Tables) HTML 89K
46: R32 Convertible Promissory Notes - Related Party HTML 34K
(Tables)
47: R33 Notes Payable (Tables) HTML 48K
48: R34 Note Payable - Related Party (Tables) HTML 30K
49: R35 Stockholders' Equity (Deficit) (Tables) HTML 70K
50: R36 Fair Value (Tables) HTML 80K
51: R37 Income Taxes (Tables) HTML 84K
52: R38 Nature of Operations - Additional Information HTML 55K
(Detail)
53: R39 Summary of Significant Accounting Policies - HTML 72K
Additional Information (Detail)
54: R40 Summary of Significant Accounting Policies - HTML 40K
Schedule of Company's Revenue By Contract Type
(Detail)
55: R41 Acquisitions - Additional Information (Detail) HTML 65K
56: R42 Acquisitions - Schedule of Assets and Liabilities HTML 158K
Acquired (Detail)
57: R43 Acquisitions - Schedule of Assets and Liabilities HTML 34K
Acquired (Parenthetical) (Detail)
58: R44 Acquisitions - Schedule of Business Acquisition, HTML 33K
Pro Forma Information (Detail)
59: R45 Fixed Assets - Summary of Fixed Assets (Detail) HTML 43K
60: R46 Fixed Assets - Additional Information (Details) HTML 28K
61: R47 Intangible Assets and Goodwill - Schedule of HTML 58K
Intangible Assets (Detail)
62: R48 Intangible Assets and Goodwill - Additional HTML 32K
Information (Detail)
63: R49 Intangible Assets and Goodwill - Schedule of HTML 42K
Future Amortization of Intangible Assets (Detail)
64: R50 Intangible Assets and Goodwill - Schedule of HTML 52K
Goodwill (Detail)
65: R51 Convertible Promissory Notes - Related Party - HTML 46K
Schedule of Convertible Promissory Notes, Related
party (Detail)
66: R52 Convertible Promissory Notes - Related Party - HTML 70K
Additional Information (Detail)
67: R53 Convertible Promissory Notes - Related Party - HTML 50K
Schedule of Convertible Promissory Notes, Related
party (Parenthetical) (Details)
68: R54 Notes Payable - Schedule of Notes Payable (Detail) HTML 47K
69: R55 Notes Payable - Schedule of Notes Payable HTML 97K
Narrative (Detail)
70: R56 Notes Payable - Additional Information (Detail) HTML 47K
71: R57 Notes Payable - Schedule of Repayment, Net of HTML 39K
Discounts (Detail)
72: R58 Note Payable - Related Party - Schedule Of Notes HTML 35K
Payable To Related Party (Details)
73: R59 Note Payable - Related Party - Additional HTML 32K
Information (Details)
74: R60 Amount Due To Seller - Additional Information HTML 60K
(Detail)
75: R61 Stockholders' Equity (Deficit) - Additional HTML 189K
Information (Detail)
76: R62 Stockholders' Equity (Deficit) - Schedule of HTML 43K
warrants (Detail)
77: R63 Stockholders' Equity (Deficit) - Schedule of HTML 73K
options (Detail)
78: R64 Stockholders' Equity (Deficit) - Schedule of Stock HTML 41K
Options, Valuation Assumptions (Detail)
79: R65 Fair Value - Summary of Derivative Liabilities and HTML 51K
the Contingent Earn out Fall (Detail)
80: R66 Fair Value - Summary of Derivative liabilities HTML 47K
(Detail)
81: R67 Fair Value - Additional Information (Detail) HTML 28K
82: R68 Fair Value - Summary of Change in the Fair Value HTML 36K
of the Derivative Liabilities (Detail)
83: R69 Fair Value - Summary of Fair Value Measurements HTML 52K
(Detail)
84: R70 Related-Party Transactions - Additional HTML 43K
Information (Details)
85: R71 Defined Contribution Plan (Details) HTML 27K
86: R72 Commitments - Additional Information (Details) HTML 220K
87: R73 Income Taxes - Schedule of Effective Income Tax HTML 46K
Rate Reconciliation (Details)
88: R74 Income Taxes - Schedule of Deferred Tax Assets and HTML 63K
Liabilities (Details)
89: R75 Income Taxes - Additional Information (Detail) HTML 27K
90: R76 Income Taxes - Schedule of Components Of Income HTML 36K
Tax Expense (Details)
91: R77 Subsequent Events (Details) HTML 170K
92: R9999 Uncategorized Items - ctm-20231231.htm HTML 31K
94: XML IDEA XML File -- Filing Summary XML 174K
97: XML XBRL Instance -- ctm-20231231_htm XML 2.12M
93: EXCEL IDEA Workbook of Financial Report Info XLSX 222K
11: EX-101.CAL XBRL Calculations -- ctm-20231231_cal XML 275K
12: EX-101.DEF XBRL Definitions -- ctm-20231231_def XML 1.20M
13: EX-101.LAB XBRL Labels -- ctm-20231231_lab XML 2.38M
14: EX-101.PRE XBRL Presentations -- ctm-20231231_pre XML 1.61M
10: EX-101.SCH XBRL Schema -- ctm-20231231 XSD 290K
95: JSON XBRL Instance as JSON Data -- MetaLinks 642± 961K
96: ZIP XBRL Zipped Folder -- 0001877939-24-000018-xbrl Zip 557K
‘EX-97.1’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
Revised and adopted by the Board of Directors on November 9, 2023
Each current or former executive officer shall repay or forfeit, to the fullest extent permitted by law and as directed by the independent members of the Board of Directors as identified pursuant to applicable exchange listing standards (“Independent Directors”) of Castellum, Inc. (“Company,”), any annual incentive
or other performance-based compensation awards (“Awards”) received by him or her, if:
a.the payment, grant, or vesting of the Awards was based on the achievement of financial results that were subsequently the subject of a restatement of the Company’s financial statements filed with the Securities and Exchange Commission; and
a.the amount of the compensation that would have been received by the executive officer had the financial results been properly reported would have been lower than the amount actually received.
The Independent Directors shall have full and final authority to make all determinations under
this policy, including without limitation whether the policy applies and whether any recovery would be deemed impracticable. Repayment can be made from the proceeds of the sale of Company stock and the forfeiture of other outstanding awards. All determinations and decisions made by the Board’s Independent Directors pursuant to the provisions of this policy shall be final, conclusive, and binding on all persons, including the Company, its affiliates, its stockholders, and employees.
Each Award agreement or other document setting forth the terms and conditions of any annual incentive or other performance-based Award granted to an executive officer shall be deemed to include the provisions of this policy. The remedy specified in this policy shall not be exclusive and shall be in addition to every other right or
remedy at law or in equity that may be available to the Company.
